Candy Tsourounis, PharmD

Professor
Department of Clinical Pharmacy
Tsourounis
Marco Sanchez
[email protected]
Phone: +1 415 502-5091
521 Parnassus Avenue, Rm 3516
UCSF Box 0622
San Francisco, CA 94117
United States

Links

UCSF Profiles

Affiliations

Education programs

PharmD Degree Program

UCSF centers, institutes, and research programs

Faculty Member, Medication Outcomes Center

What I do

I evaluate how medicines are used at UCSF Health. I work with other healthcare providers to measure and assess the value of the medicines that we use to treat patients. I also help manage the UCSF medicine formulary by working with other healthcare providers to select the most effective medicines, ensuring that they will be used in a cost-effective and safe manner to improve the care of all UCSF patients.

Departmental research area

clinical research

My research expertise

medication-related research, evidence-based analysis, evaluating pharmaceutical models of care, continuous quality improvement

Clinical expertise

drug information, integrative and complementary therapies, dietary supplements

Professional background

Degrees

PharmD, University of Illinois at Chicago, 1993

Licensure and certifications

Licentiate in Pharmacy, California State Board of Pharmacy, 1993

Biography

Dr. Candy Tsourounis is Professor of Clinical Pharmacy in the Department of Clinical Pharmacy in the School of Pharmacy at the University of California San Francisco. Dr. Tsourounis is involved in providing evidence-based reviews of recently approved prescription medications and performing medication utilization analyses in the Department's Medication Outcomes Center.

Dr. Tsourounis has various areas of research interest including value-based care, quality improvement, implementation science, evidence-based practice, and dietary supplements. Dr. Tsourounis’ research focus has been on dietary supplements and drug-supplement interactions. Currently, Dr. Tsourounis is very interested in demonstrating the value of pharmacists in medication management and value-based initiatives. Dr. Tsourounis is very involved in educating consumers and health professionals on the rational use of medicines. Dr. Tsourounis serves as a clinical consultant and editor for various drug-related publications and computer software programs used by pharmacists and pharmacy learners worldwide. She has coordinated various continuing education programs for national pharmacy societies and serves as a speaker nationally and internationally on the practice of pharmacy.

Research keywords

  • Delivery of Health Care
  • Legislation, Food
  • Vitamins
  • Phytotherapy
  • Adrenal Cortex Hormones
  • Electronic Nicotine Delivery Systems
  • dietary supplements
  • Tobacco Products
  • Chinese Herbal Drugs
  • United States Food and Drug Administration
  • Trace Elements
  • Complementary Therapies
  • Osteoporosis, Postmenopausal
  • Minerals
  • Metered Dose Inhalers

Publications

Apollonio DE, Dennehy CE, Tsourounis C, Wakefield T. An Observational Study of Regulatory Violations Related to Online Tobacco Product Marketing and Retailer Responses to US FDA Warning Letters. Tob Use Insights. 2024; 17:1179173X241300825.
Tsourounis C, Chatterjee A, Pherson EC, Auron M. Transforming Health Care from Volume to Value: Targeting Essential Therapies for Improved Health. Am J Med. 2024 Oct; 137(10):943-948.
Lai S, Yu C, Dennehy CE, Tsourounis C, Lee KP. Online Marketing of Ephedra Weight Loss Supplements: Labeling and Marketing Compliance with the U.S. Food and Drug Administration Ban on Ephedra. J Altern Complement Med. 2021 Sep; 27(9):796-802.
Chu CE, Law L, Zuniga K, Lin TK, Tsourounis C, Rodriguez-Monguio R, Lazar A, Washington SL, Cooperberg MR, Greene KL, Carroll PR, Pruthi RS, Meng MV, Chen LL, Porten SP. Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy. Urology. 2021 Mar; 149:168-173.
Nguyen H, Dennehy CE, Tsourounis C. Violation of US regulations regarding online marketing and sale of e-cigarettes: FDA warnings and retailer responses. Tob Control. 2020 12; 29(e1):e4-e9.
Josette Rivera, MD, Rosalind de Lisser, RN, Anand Dhruva, MD, Amber Fitzsimmons, PT, Susan Hyde, DDS, PhD. Integrative Health: An Interprofessional Standardized Patient Case for Prelicensure Learners. MedEdPORTAL The Journal of Teaching and Learning Resources. 2018; 10715(14):1-8.
Rivera J, de Lisser R, Dhruva A, Fitzsimmons A, Hyde S, Reddy S, Tsourounis C, Adler SR. Integrative Health: An Interprofessional Standardized Patient Case for Prelicensure Learners. MedEdPORTAL. 2018 05 04; 14:10715.
Hsu O, Tsourounis C, Chan LL, Dennehy C. Chinese Herb Use by Patients at a San Francisco Chinatown Public Health Center. J Altern Complement Med. 2016 Sep; 22(9):751-6.
Corelli RL, Muchnik MA, Beechinor RJ, Fong G, Vogt EM, Cocohoba JM, Tsourounis C, Hudmon KS. Perceptions and Cost-Analysis of a Multiple Mini-Interview in a Pharmacy School Admissions Process. Am J Pharm Educ. 2015 Nov 25; 79(9):135.
Hardmeier A, Tsourounis C, Moore M, Abbott WE, Guglielmo BJ. Pediatric medication administration errors and workflow following implementation of a bar code medication administration system. J Healthc Qual. 2014 Jul-Aug; 36(4):54-61; quiz 61-3.
Tasaka CL, Burg C, VanOsdol SJ, Bekeart L, Anglemyer A, Tsourounis C, Rennke S. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units. Ann Pharmacother. 2014 Apr; 48(4):462-9.
Ambrose PJ, Tsourounis C, Uryasz FD, Patterson E. Characteristics and trends of drug and dietary supplement inquiries by college athletes. J Am Pharm Assoc (2003). 2013 May-Jun; 53(3):297-303.
Burrell C, Tsourounis C, Quan D, Jue V, Tam E, Guglielmo BJ. Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital. Hosp Pharm. 2013 Apr; 48(4):302-7.
Robinson CA, Tsourounis C. Inhaled corticosteroid metered-dose inhalers: how do variations in technique for solutions versus suspensions affect drug distribution? Ann Pharmacother. 2013 Mar; 47(3):416-20.
Pushkin R, Frassetto L, Tsourounis C, Segal ES, Kim S. Improving the reporting of adverse drug reactions in the hospital setting. Postgrad Med. 2010 Nov; 122(6):154-64.
Dennehy C, Tsourounis C, Bui L, King TL. The use of herbs by california midwives. J Obstet Gynecol Neonatal Nurs. 2010 Nov-Dec; 39(6):684-93.
Dennehy C, Tsourounis C. A review of select vitamins and minerals used by postmenopausal women. Maturitas. 2010 Aug; 66(4):370-80.
Tsourounis C, Bent S. Why change is needed in research examining dietary supplements. Clin Pharmacol Ther. 2010 Feb; 87(2):147-9.
Ambrose PJ, Tsourounis C, Olander R, Uryasz F. Characteristics of drug and dietary supplement inquiries by college athletes. Sports Health. 2010 Jan; 2(1):12-8.
Frassetto LA, Poon S, Tsourounis C, Valera C, Benet LZ. Effects of uptake and efflux transporter inhibition on erythromycin breath test results. Clin Pharmacol Ther. 2007 Jun; 81(6):828-32.
Nicandro JP, Tsourounis C, Frassetto L, Guglielmo BJ. In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4. J Herb Pharmacother. 2007; 7(1):39-56.
Tam JW, Dennehy CE, Ko R, Tsourounis C. Analysis of ephedra-free labeled dietary supplements sold in the San Francisco Bay area in 2003. J Herb Pharmacother. 2006; 6(2):1-19.
Dennehy CE, Tsourounis C, Miller AE. Evaluation of herbal dietary supplements marketed on the internet for recreational use. Ann Pharmacother. 2005 Oct; 39(10):1634-9.
Dennehy CE, Tsourounis C, Horn AJ. Dietary supplement-related adverse events reported to the California Poison Control System. Am J Health Syst Pharm. 2005 Jul 15; 62(14):1476-82.
Ulbricht C, Basch E, Boon H, Ernst E, Hammerness P, Sollars D, Tsourounis C, Woods J, Bent S. Safety review of kava (Piper methysticum) by the Natural Standard Research Collaboration. Expert Opin Drug Saf. 2005 Jul; 4(4):779-94.
Cheng J, Lee P, Li J, Dennehy CE, Tsourounis C. Use of Chinese herbal products in Oakland and San Francisco Chinatowns. Am J Health Syst Pharm. 2004 Apr 01; 61(7):688-94.
Yoshizumi WM, Tsourounis C. Effects of creatine supplementation on renal function. J Herb Pharmacother. 2004; 4(1):1-7.
Assemi M, Torres NM, Tsourounis C, Kroon LA, McCart GM. Assessment of an online consumer "Ask Your Pharmacist" service. Ann Pharmacother. 2002 May; 36(5):787-92.
Yang S, Dennehy CE, Tsourounis C. Characterizing adverse events reported to the California Poison Control System on herbal remedies and dietary supplements: a pilot study. J Herb Pharmacother. 2002; 2(3):1-11.
Kam IW, Dennehy CE, Tsourounis C. Dietary supplement use among menopausal women attending a San Francisco health conference. Menopause. 2002 Jan-Feb; 9(1):72-8.
Nelsen J, Ulbricht C, Barrette EP, Sollars D, Tsourounis C, Rogers A, Basch S, Hashmi S, Bent S, Basch E. Red clover (Trifolium pratense) monograph: a clinical decision support tool. J Herb Pharmacother. 2002; 2(3):49-72.
Hammerness P, Ulbricht C, Barrette EP, Boon H, Szapary P, Sollars D, Smith M, Tsourounis C, Bent S, Basch E. Shark cartilage monograph: a clinical decision support tool. J Herb Pharmacother. 2002; 2(2):71-93.
Tsourounis C. Clinical effects of phytoestrogens. Clin Obstet Gynecol. 2001 Dec; 44(4):836-42.
Howard N, Tsourounis C, Kapusnik-Uner J. Dietary supplement survey of pharmacists: personal and professional practices. J Altern Complement Med. 2001 Dec; 7(6):667-80.
Tsui B, Dennehy CE, Tsourounis C. A survey of dietary supplement use during pregnancy at an academic medical center. Am J Obstet Gynecol. 2001 Aug; 185(2):433-7.
Le J, Tsourounis C. Implanon: a critical review. Ann Pharmacother. 2001 Mar; 35(3):329-36.
Barclay TS, Tsourounis C, McCart GM. Comment: glucosamine: selecting appropriate study exclusion criteria. Ann Pharmacother. 1998 Dec; 32(12):1371-2.
Tsourounis C. The JAMA patient page. JAMA. 1998 Oct 14; 280(14):1232.
Barclay TS, Tsourounis C, McCart GM. Glucosamine. Ann Pharmacother. 1998 May; 32(5):574-9.
Tsourounis C, Schroeder DJ. Implementation of a computerized drug information database. Am J Health Syst Pharm. 1997 Aug 01; 54(15):1763-4.
Tsourounis C, Guglielmo BJ. Aerosolized amphotericin B in prophylaxis of pulmonary aspergillosis. Ann Pharmacother. 1996 Oct; 30(10):1175-6.